,i  #aag? ,,congress  #a/ ,session  ,h4 
,r4 #edce  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,septemb] #cj1 #bjba  
,mr4 ,blum5au] 7= himself1 ,mr4         
,pascrell1 & ,mr4 ,bacon7 introduc$ !   
foll[+ bill2 :i* 0 ref]r$ to !          
,committee on ,en]gy & ,comm]ce  ,a     
,,bill  ,to am5d ! ,f$]al ,food1 ,drug1 
& ,cosmetic ,act to direct ! ,secret>y (
 ,heal? & ,human ,s]vices to e/abli% a  
,neurosci5ce ,c5t] ( ,excell5ce & a     
,neurosci5ce ,translation ,work+ ,gr\p1 
& = o!r purposes4  #a4 ,%ort title ,?is 
,act may be cit$ z ! ,br++ ,regulatory  
,advances ,into ,neurosci5ce ,act (     
#bjba or ! ,,bra9 ,act ( #bjba4  #b4    
,f9d+s ,congress f9ds ! foll[+3  7#a7 ,!
 bra9 & c5tral n]v\s sy/em make up !    
body's mo/ complex organ sy/em4  7#b7   
,ne>ly "o 9 five adults 9 ! ,unit$      
,/ates 7m ?an #ej million7 live ) a     
m5tal illness1 disproportionately       
impact+ wom51 p report+ two or m races1 
& individuals "u age fifty4  7#c7       
,neuropsy*iatric disord]s are ! lead+   

cause ( disability 9 ! ,nation1 mak+ up 
#ah4g p]c5t ( ye>s lo/ to disability &  
premature dea?4  7#d7 ,bra9 disord]s1   
injuries1 & diseases are e/imat$ to co/ 
! ,unit$ ,/ates m ?an #a4e trillion p]  
ye>4  7#e7 ,m5tal heal? & sub/ance use  
disord] treatm5t sp5d+ is expect$ to    
total #bhj4e billion 9 #bjbj4  7#f7 ,!  
,,s>s-,co,v-#b virus c cause s]i\s      
psy*iatric & neurologic effects & !     
,,covid-#ai p&emic has exac]bat$ ! burd5
 ( bra9 & c5tral n]v\s sy/em conditions4
  7#g7 ,products t>get+ ! bra9 & c5tral 
n]v\s sy/em1 includ+ ^? conditions ) few
 or no approv$ treatm5ts1 take long] to 
develop & are less likely to be approv$ 
?an products = o!r disease areas4  #c4  
,in/itute & advisory committee =        
diseases affect+ ! bra9 or c5tral n]v\s 
sy/em  7a7 ,e/abli%m5t ( ,neurosci5ce   
,c5t] ( ,excell5ce ,section #ajad ( !   
,f$]al ,food1 ,drug1 & ,cosmetic ,act   
7#ba ,u4,s4,c4 #cii;g7 is am5d$ by add+ 
at ! end ! foll[+3  7e7 ,neurosci5ce    
,c5t] ( ,excell5ce  7#a7 ,9 g5]al ,!    

,secret>y %all e/abli% an in/itute "u   
subsection 7a7 to be kn[n z !           
,neurosci5ce ,c5t] ( ,excell5ce to c>ry 
out activities "u su* subsection )      
respect to a major disease area or areas
 affect+ ! bra9 or c5tral n]v\s sy/em4  
7#b7 ,au?orization ( appropriations ,!re
 are au?oriz$ to be appropriat$ to c>ry 
out ?is subsection #be1jjj1jjj = ea* (  
fiscal ye>s #bjbc ?r\gh #bjbg4  4  7b7  
,neurosci5ce ,translation ,work+ ,gr\p  
,*apt] ,x ( ! ,f$]al ,food1 ,drug1 &    
,cosmetic ,act 7#ba ,u4,s4,c4 #cia et   
seq47 is am5d$ by add+ at ! end !       
foll[+3  #ajae4 ,neurosci5ce            
,translation ,work+ ,gr\p  7a7          
,e/abli%m5t ,! ,secret>y %all e/abli% & 
ma9ta9 an advisory bo>d to be kn[n z !  
,neurosci5ce ,translation ,work+ ,gr\p  
to advise ! ,director ( ! ,neurosci5ce  
,c5t] ( ,excell5ce "u section #ajad7;e7 
7or ! ,commission] ( ,food & ,drugs 9   
accordance ) subsection 7c77 on !       
foll[+3  7#a7 ,issues ) respect to      
translat+ neurosci5ce discov]ies to     

approv$ treatm5ts = diseases &          
conditions affect+ ! bra9 or c5tral     
n]v\s sy/em4  7#b7 ,activities to       
increase ! translation ( neurosci5ce    
discov]ies to su* approv$ treatm5ts4    
7#c7 ,! developm5t ( guidance ) respect 
to diseases & conditions affect+ ! bra9 
or c5tral n]v\s sy/em4  7#d7 ,fund+1    
collaboration1 & o!r opportunities )9 ! 
,national ,in/itute ( ,neurological     
,disord]s & ,/roke1 ,national ,c5t] =   
,advanc+ ,translational ,sci5ces1 or o!r
 ,gov]nm5t entities to increase !       
translation ( neurosci5ce discov]ies to 
su* approv$ treatm5ts4  7#e7 ,!         
incorporation ( pati5t pref]5ces1       
pati5t-report$ outcomes1 & real-_w data 
9 ! developm5t ( regulations4  7b7      
,memb]%ip ,! ,neurosci5ce ,translation  
,work+ ,gr\p %all consi/ ( n m ?an eight
 memb]s1 includ+--  7#a7 ! ,director ( !
 ,national ,in/itute ( ,neurological    
,disord]s & ,/roke 7or designee72  7#b7 
! ,director ( ! ,national ,c5t] =       
,advanc+ ,translational ,sci5ces 7or    

designee72  7#c7 ?ree repres5tatives f  
pati5t advocacy or national             
organizations t focus on injuries1      
diseases1 or disord]s affect+ ! bra9 or 
c5tral n]v\s sy/em1 includ+             
organizations t repres5t s]vice deliv]y 
= pati5ts2  7#d7 two exp]ts ) exp]i5ce  
conduct+ cl9ical trials ) respect to    
diseases & conditions affect+ ! bra9 or 
c5tral n]v\s sy/em2 &  7#e7 "o exp]t )  
exp]tise 9 ! regulation ( drugs1        
devices1 & biological products4  7c7    
,t]m9ation ( ,neurosci5ce ,c5t] (       
,excell5ce ,if ! ,secret>y1 pursuant to 
section #ajad7;d71 t]m9ates !           
,neurosci5ce ,c5t] ( ,excell5ce "u      
section #ajad7;e71 ! ,neurosci5ce       
,translation ,work+ ,gr\p %all advise ! 
,commission] ( ,food & ,drugs4  4  7c7  
,applicability ,sections #ajad7;e7 &    
#ajae ( ! ,f$]al ,food1 ,drug1 &        
,cosmetic ,act1 z add$ by ?is section1  
%all apply on ! date t is n lat] ?an "o 
ye> aft] ! date ( ! enactm5t ( ?is ,act4